The latest guidance from the Department of Health and Social Care follows the awarding of medicines and medical products contracts as part of ‘no deal’ preparations earlier this month.
The CQC reported that some service users experienced avoidable harm and needed hospital treatment after delivery dates for the medicines were missed or delayed.
